Culturing of cells require an appropriate culturing environment for successful cell development. The culturing environment is maintained utilizing culture media, supplements for growth, and reagents. Cell expansion systems also ensure to simplify the overall task and to reduce labor-intensive manual tasks which are associated with the process.
Cell Expansion Market: Overview
Cell culturing is bioreactors is regulated process and requires controlled environmental conditions such as regulated gas content for the growth of the cells, monitored flow rates, ambient temperature, pH, agitation of cells, and controlled circulation of cells. Cell expansion bioreactors can be used for various purposes such as clinical research, translational research, and process development. The launch of cell expansion bioreactors is time efficient and does not require regular cleaning or sterilization. The advantage of using cell expansion systems in pharmaceutical, biotechnology or research institutes is that these systems are highly reliable, and ensures that the mixing and aeration of cell culture are appropriate. The system for cell expansion comprises a base unit, gas mixture, pump, temperature controlled unit, weight measurement, data storage, communication, environment controlled unit and installed software.
|Get Sample Copy of This Report @ https://www.persistencemarketresearch.com/samples/15757|
Cell Expansion Market: Segmentation
The cell expansion market is segmented by products, cell type, applications, end users, and regions:
- Kits and Consumables
Consumables segment includes reagents, media, serum, and disposables. Instrument segment includes cell expansion systems, and automatic cell expansion systems.
By Cell Types:
- Human Cells
- Animal Cells
- Regenerative Medicine
- Cancer Research
- Stem Cell Research
By End Users:
- Biopharmaceutical Companies
- Biotechnology Companies
- Academic Research
- Research Institutes
Cell Expansion Market: Drivers and Restraints
Cell expansion market is anticipated to grow during the forecast years as many multi-national companies are focusing towards launching of new systems for cell expansion. Also, cell expansion market would grow owing to the government regulations and fundings. Government Institutes release funds for stem cell research and other research which will accelerate the market for cell expansion systems. Multi-national companies are investing in the manufacturing of cell expansion systems as they minimize the risk of contamination, increases the cell density, controlled cell expansion, and is suitable for utilization in the regulatory environment.
Cell Expansion Market: Region-wise Outlook
Geographically, the cell expansion market is segmented into North America, Latin America, Europe, Asia-Pacific and the Middle East and Africa. North America leads the market for cell expansion owing to advancement in biotechnology and pharmaceutical companies. In the North America region, manufacturers are focusing on developing products with advanced sensors, and intelligent control strategies. Europe is the second leading market for cell expansion due to increased funding and support in cell-based research. The Asia Pacific cell expansion market is also anticipated to grow at an increasing rate owing to increasing research expenditure in emerging economies. Asia Pacific region is accounted as a fastest growing region for cell expansion products as many players have invested in the development of new therapy products. These factors are likely to drive the market growth of cell expansion market during the forecast period globally.
|Request For Customization of This Report @ https://www.persistencemarketresearch.com/request-customization/15757|
Cell Expansion Market: Key Players
The major players in cell expansion market include Beckman Coulter, Inc, Thermo Fisher Scientific, Inc., Becton, Dickinson and Company, Terumo BCT, Inc., Corning, Inc., Stemcell Technologies, Inc., GE Healthcare, Merck KGaA (Sigma-Aldrich Co. LLC), Lonza, Miltenyi Biotec among others. Companies have several ongoing research for cell-based therapies and stem cell-based therapies; it has been found that companies are in the development of new products and systems which ensure market growth during the forecast period. Only a few manufacturing companies are involved in the manufacturing of cell expansion instruments.